Drug-induced neurologic disorders

K K Jain MD (Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Originally released July 5, 2000; last updated July 5, 2016; expires July 5, 2019

This article includes discussion of drug-induced neurologic disorders, adverse drug reactions, drug-disease interactions, iatrogenic neurologic disorders, and neurotoxicity. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.

Overview

The term "drug-induced neurologic disorders" refers to unintended or undesirable effects on the nervous system caused by drugs or associated with drug use. These may be drugs for neurologic or other diseases. This article discusses the pathophysiology, epidemiology, diagnosis, and treatment of drug-induced neurologic disorders. The toxic effect on the nervous system may be primary or secondary to systemic effects of the drug. Pharmacogenetics, the study of influence of genetic factors on the action of drugs, is relevant to adverse drug reactions. Polymorphisms in the genes that code for drug-metabolizing enzymes, drug transporters, drug receptors, and ion channels can affect an individual's risk of having an adverse drug reaction. The approach to management is prevention and withdrawal of the drug responsible for the adverse reaction. Genotyping may identify patients who would develop adverse reactions to certain drugs; those drugs should be avoided in the identified subsets of patients.

Key points

 

• Drug-induced neurologic disorders are unintended adverse effects on the nervous system caused by drugs or associated with drug use.

 

• These should be considered in the differential diagnosis of neurologic disorders.

 

• The adverse effects may be reversible by discontinuation of the suspected drug, but neurologic damage may persist in some cases.

 

• An awareness of these adverse effects is important for improving safety of pharmacotherapy of neurologic disorders.

 

• An understanding of the pathomechanism of drug-induced neurologic disorders may be useful for treating these complications.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.